| Market Cap | ₹1,36,190Cr |
| ROE | 25.33% |
| P/E Ratio(TTM) | 63.64 |
| EPS(TTM) | 63.23 |
| P/B Ratio | 16.12 |
| Dividend Yield | 0.15% |
| Industry P/E | 31.72 |
| Book Value | 249.65 |
| Debt to Equity | 0.33 |
| Face Value | 5 |
| Managing Director | NA |
| NSE Symbol | TORNTPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Ajanta Pharma | NA (0.00%) | 34.86 | ||
| Gland Pharma | NA (0.00%) | 35.89 | ||
| Eris Lifesciences | NA (0.00%) | 43.74 | ||
| Sai Life Sciences | NA (0.00%) | 60.85 |